Market Cap (In CNY)
7.7 Billion
Revenue (In CNY)
1.9 Billion
Net Income (In CNY)
106.49 Million
Avg. Volume
4.39 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 9.09-25.16
- PE
- -
- EPS
- -
- Beta Value
- 0.813
- ISIN
- CNE100004223
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ms. Jinping Liu
- Employee Count
- -
- Website
- https://www.huluwayaoye.com
- Ipo Date
- 2020-07-10
- Details
- Hainan Huluwa Pharmaceutical Group Co., Ltd. engages in the research and development, production, and sale of drugs in the areas of Children's respiratory and digestive systems in China. Its primary products include 4 grams of pediatric lung heat cough granules and capsules. The company was founded in 2005 and is based in Haikou, China.
More Stocks
-
141080LegoChem Biosciences, Inc.
141080
-
HTZWW
-
034300
-
TTLTFTotal Telcom Inc.
TTLTF
-
BRK
-
DEF
-
603600UE Furniture Co., Ltd.
603600
-
DZRD